Group 1 - The company reported a revenue of 150 million yuan in the first half of 2025, representing a year-on-year growth of 2.16%, and a net profit attributable to shareholders of 11.0458 million yuan, up 5.94% year-on-year [1] - The global low-temperature storage industry is experiencing increased competition and a shift in market dynamics, prompting the company to focus on the life sciences sector and enhance operational capabilities [1][3] - The company aims to improve management efficiency and service levels while driving business scale and profitability through innovation in product development and channel upgrades [1] Group 2 - Established in 2002, the company is one of the early entrants in the ultra-low temperature storage for biological cells, offering a range of products including low-temperature storage boxes and biological safety cabinets [2] - The company's products are widely used in various sectors such as medical systems, blood systems, disease control, and biopharmaceutical enterprises, contributing to its recognition as a high-tech enterprise and a national-level specialized "little giant" [2] - The company has received numerous awards, including the National Technology Invention Award (second class) and the China International Industrial Expo Silver Award, highlighting its innovation and contributions to the industry [2] Group 3 - The company adheres to a business philosophy centered on technology, product, market orientation, and customer focus, achieving breakthroughs in core refrigeration technology for the biomedical field [3] - It implements a product synergy strategy that focuses on the entire sample ecosystem and aims to become a global leader in customized system solutions for the life sciences sector [3]
中科美菱（835892）2025年上半年营收、净利润实现双增长 聚焦于生命科学领域